Featured Jobs
|
Retirement Plan Analyst - DC Plans M2B Retirement Consulting LLC
|
|
TPA Retirement Plan Relationship Manager ERISA Services Inc.
|
|
Retirement Plan Administration Consultant Blue Ridge Associates
|
|
Senior Internal Sales Consultant EPIC RPS
|
|
DWC - The 401(k) Experts
|
|
Senior Retirement Plan Analyst - DC Plans M2B Retirement Consulting LLC
|
|
Daybright Financial
|
|
BPAS
|
|
ESOP Administration Consultant Blue Ridge Associates
|
|
Director of Regulatory Operations and Compliance PCS Retirement
|
|
Conversion & Installation Manager ERISA Services, Inc.
|
|
Retirement Plan Administrator - Plan Terminations Compass
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Novo, Lilly to Sell Obesity Drugs Directly to Employers
Seeking Alpha; login may be required 
Nov. 21, 2025 "Starting from Jan. 1, the pharma giants will offer their obesity drugs Wegovy and Zepbound through Waltz Health, a digital health company focused on helping employers buy affordable medications. Under the offering, employers will procure the injectables by paying upfront, fixed prices without involving rebates and fees, which are usually paid to PBMs as part of traditional drug purchases." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |